PROFESSIONAL SUMMARY
Pharmaceutical quality and regulatory professional with 6+ years of experience spanning R&D, regulatory affairs, and quality assurance. Successfully led WHO Prequalification initiatives for critical anti-TB medications that elevated organizational compliance to international standards. Complemented extensive pharmaceutical industry leadership with a US-earned MPH to develop a comprehensive perspective that integrates quality systems expertise with broader public health implications. Offers a unique combination of international pharmaceutical development experience, global health organization collaboration, and US education in public health systems.
PROFESSIONAL EXPERIENCE
Policy Data Analyst (Capstone Project)
Community of International Neonatal Nurses (COINN), Yardley, PA, USA February 2023 – May 2024
Co-authored manuscript on neonatal mortality outcomes (under review for publication)
Led Quality Improvement Project aligned with WHO guidelines, applying US public health frameworks
Conducted program evaluation and impact assessment
Collaborated with international stakeholders to advocate for evidence-based neonatal care practices
Applied advanced statistical analysis techniques using SAS and other biostatistical methods during MPH coursework and research projects.
Demonstrated expertise in systematic literature reviews, research proposal development, and manuscript preparation leading to refereed publication submissions.
Strong proficiency with Microsoft Office Suite (Word, Excel, PowerPoint) and analytical tools including RStudio for data management, visualization, and reporting.
Hands-on experience managing large health datasets, validating data, and conducting epidemiological analyses for policy-relevant research studies.
Knowledgeable in both qualitative and quantitative research methodologies, including survey design, focus groups, and epidemiological modeling.
Practical exposure to health policy research and quality improvement initiatives through collaboration with international health organizations (e.g., WHO).
Research background includes primary care and neonatal health topics, emphasizing digital health surveillance systems and the quality use of medicines.
Developed and implemented open-source analytical resources to enhance healthcare professional decision-making and global health data transparency.
Head RND Global Markets and Regulatory Affairs
DRK Pharma Solutions GmbH, Switzerland January 2020 – January 2023
Led the establishment of DRK Pharma Solutions in Switzerland, a specialized product development company created based on success of the WHO PQ initiative
Built and trained new R&D teams to meet stringent WHO and EU regulatory standards while adapting to diverse client-specific requirements
Developed comprehensive systems for pharmaceutical product development that accommodated varied global regulatory frameworks
Successfully managed transition from internal product development to client-focused pharmaceutical services
Generated approximately $14 million in revenue through implementation of effective R&D systems and processes
Supervised cross-cultural team of 15 scientists ensuring project execution and regulatory compliance
Positioned company as a trusted partner for pharmaceutical development meeting international standards
My background in developing documentation systems following ALCOA+ principles and implementing 21 CFR Part 11 compliance provides me with the expertise needed to serve as a Subject Matter Expert for Change Controls in a regulated biopharmaceutical environment
Head RND Global Markets & Corporate Compliance (GxP)
Remington Pharmaceutical Industries, Lahore, Pakistan April 2017 – January 2020
Created and submitted the first product dossier ever accepted by WHO PQ from Remington, achieving a landmark regulatory milestone through meticulous documentation and persistence
Served as primary liaison with WHO inspectors and assessors, effectively communicating complex technical information and negotiating acceptable solutions
Led cross-functional response teams to address WHO feedback on both dossier submissions and facility inspections
Implemented comprehensive quality management systems (QMS) including root cause analysis, CAPA processes, effectiveness checks, and timeline management
Developed tracking systems to monitor progress across multiple departments, ensuring timely completion of regulatory commitments
documentation to ensure compliance with international standards
Developed and implemented documentation systems following ALCOA and ALCOA+ principles, establishing new data integrity standards
Served as primary liaison with WHO inspectors and assessors, effectively communicating complex technical information
Led cross-functional response teams to address WHO feedback on both dossier submissions and facility inspections
Implemented quality management systems including root cause analysis, CAPA processes, and effectiveness checks
Conducted critical QMS training sessions that elevated company-wide understanding of international compliance requirements
Successfully navigated workplace challenges through effective communication and focus on common organizational goals
Spearheaded the development of Levofloxacin 250 mg anti-TB medication, making Remington the first national company to achieve WHO Prequalification
Company success with WHO PQ under my leadership directly led to the creation of DRK Pharma Solutions to serve international markets
EDUCATION
Master of Public Health (MPH), Epidemiology and Health Analytics
The College of New Jersey, Ewing, NJ 2022-2024 President, Graduate Student Organization (2022-2023)
Doctor of Pharmacy (Pharm.D)
Punjab University College of Pharmacy, Pakistan 2011-2016
Bachelor of Science (BSc)
University of The Punjab, Pakistan 2013-2015
CERTIFICATIONS & PROFESSIONAL DEVELOPMENT
MIT Sloan Artificial Intelligence in Pharma and Biotech (2023)
Health Literacy and Public Health, University at Albany School of Public Health, NY
WHO Prequalification Training Program for Generic Pharmaceutical Products
KEY SKILLS
Regulatory Submission Preparation & Defense
Cross-functional Team Leadership
Quality Management System Implementation
Root Cause Analysis & CAPA Management
Regulatory Communication & Negotiation
WHO Prequalification Process Expertise
Multi-market Product Development
Project Tracking & Timeline Management
Statistical Analysis & Biostatistics (R, RStudio, SPSS)
Systematic Literature Reviews & Evidence Synthesis
Research Proposal Writing & Manuscript Preparation
Health Data Management & Epidemiological Surveillance
Qualitative and Quantitative Research Methods
Policy-Oriented Health Research & Digital Health Analytics
Data Visualization and Reporting (Excel, PowerPoint, R)
Advanced Microsoft Office Suite (Word, Excel, PowerPoint)
Primary Care and Public Health Research Expertise
Global Health Collaboration and Quality Improvement Initiatives
PUBLICATIONS & PRESENTATIONS
Manuscript: "Neonatal Nurses: A Missing Link in Neonatal Mortality Outcomes" (under review)
Presenter at WHO headquarters (Copenhagen) on national pharmaceutical manufacturing standards and WHO PQ implementation
Speaker at ACT Accelerator Facilitation Council Meeting (2022)